Literature DB >> 10540021

Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis.

M J Strong1, A Rowe, R N Rankin.   

Abstract

We have performed a retrospective review of the use of a percutaneous gastrojejunostomy in patients with amyotrophic lateral sclerosis (ALS). Forty-one patients with initial bulbar manifestations of ALS and 32 patients with initial limb manifestations underwent a percutaneous gastrojejunostomy under fluoroscopic control using the Rankin gastrojejunostomy tube. Survival characteristics were compared with 86 bulbar onsetting and 207 limb onsetting ALS patients who did not require nutritional support. The 30-day mortality rate was 9.6% (respiratory death in three bulbar onsetting patients and four limb onsetting patients) and the 30 day morbidity rate was 4.1% (one operative site infection and intraperitoneal leakage in two patients). The most frequent long-term complication was the requirement for tube changing (blockage in six; dislodgment in two). Gastric reflux was not described amongst the treated patients. Overall survivorship (symptom onset to death) was less in the bulbar onsetting patients receiving a gastrojejunostomy tube than in the control population (median survival 22.0 vs. 33.7 months, respectively, P=0.005). As a group, the median survivorship for limb onsetting patients was not different for those receiving a gastrojejunostomy than for those who did not. However, a significant reduction in survival was observed in limb onsetting patients receiving a gastrojejunostomy early in the course of their disease (P=0.001) compared to those with a longer duration prior to the procedure. This was not observed in the bulbar onsetting patients. In both patient populations, no relationship was observed between survival post-gastrojejunostomy and the severity of pulmonary involvement at the time of the intervention, serum chloride, or age at onset. These studies demonstrate that a percutaneous gastrojejunostomy is a well-tolerated and safe alternative technique for enteral nutritional support in ALS patients. It also offers the advantage of not requiring either a general anaesthetic at the time of the procedure or instrumentation through the oropharynx. We have also observed that limb onsetting patients requiring a gastrojejunostomy early in the course of their illness are in a distinctive, less favorable, prognostic group.

Entities:  

Mesh:

Year:  1999        PMID: 10540021     DOI: 10.1016/s0022-510x(99)00235-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Percutaneous endoscopic gastrostomy: a safe and effective bridge for enteral nutrition in neurological or non-neurological conditions.

Authors:  Rasim Gencosmanoglu
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 2.  Amyotrophic lateral sclerosis: update for family physicians.

Authors:  Christen L Shoesmith; Michael J Strong
Journal:  Can Fam Physician       Date:  2006-12       Impact factor: 3.275

Review 3.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

Review 4.  Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Hans Dieter Katzberg; Michael Benatar
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

5.  Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register.

Authors:  Raeburn B Forbes; Shuna Colville; Robert J Swingler
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 6.  Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.

Authors:  Gary Ginsberg; Serena Lowe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Nutritional support teams increase percutaneous endoscopic gastrostomy uptake in motor neuron disease.

Authors:  Lin Zhang; Leanne Sanders; Robert J L Fraser
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

8.  A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes.

Authors:  Leila Bond; Paulamy Ganguly; Nishad Khamankar; Nolan Mallet; Gloria Bowen; Braden Green; Cassie S Mitchell
Journal:  Brain Sci       Date:  2019-09-04

9.  A Medley of Malnutrition and Myotonic Dystrophy: Twice Unlucky.

Authors:  Hajira Z Malik; Gaurav Sharma; Cesar Moreno; Siva P Parcha
Journal:  Cureus       Date:  2022-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.